Essex Savings Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Essex Savings Bank’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,652	Closed	-$280K	–	224
2021 Q4	$280K	Hold	1,652	–	–	0.09%	172
2021 Q3	$333K	Hold	1,652	–	–	0.12%	160
2021 Q2	$235K	Hold	1,652	–	–	0.09%	188
2021 Q1	$245K	Hold	1,652	–	–	0.11%	170
2020 Q4	$215K	Hold	1,652	–	–	0.1%	186
2020 Q3	$241K	Buy	+1,652	New	+$235K	0.12%	165

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Savings Bank's ALNY Position: Q1 2022 in Review

Essex Savings Bank sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2022, closing a stake of 1,652 shares — an estimated $280K sold.

Essex Savings Bank first reported a position in ALNY in Q3 2020 and held it in 6 quarters. The position peaked at $333K in Q3 2021. 444 funds tracked by Wall St. Rank hold ALNY as of Q1 2022.

Essex Savings Bank reported no remaining Alnylam Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Essex Savings Bank sold 1,652 Alnylam Pharmaceuticals shares in Q1 2022, an estimated $280K.
Essex Savings Bank first reported a position in Alnylam Pharmaceuticals in Q3 2020 and held it in 6 quarters.
Essex Savings Bank's Alnylam Pharmaceuticals position peaked at $333K in Q3 2021.
444 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2022.

Based on Essex Savings Bank's 13F filing for Q1 2022, filed 3 May 2022.